SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+61.82%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$457M
AUM Growth
+$457M
(+1.3%)
Cap. Flow
-$83.6M
Cap. Flow
% of AUM
-18.3%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
114
New
24
Increased
11
Reduced
44
Closed
23
Top Buys
| 1 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$15.5M |
| 2 |
AstraZeneca
AZN
|
$13.1M |
| 3 |
Universal Health Services
UHS
|
$11.1M |
| 4 |
Sanofi
SNY
|
$10.7M |
| 5 |
Amgen
AMGN
|
$9.2M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$17M |
| 2 |
McKesson
MCK
|
$12.3M |
| 3 |
Molina Healthcare
MOH
|
$10M |
| 4 |
AMN Healthcare
AMN
|
$9.67M |
| 5 |
Cardinal Health
CAH
|
$8.96M |
Sector Composition
| 1 | Healthcare | 87.36% |
| 2 | Technology | 1.15% |
| 3 | Consumer Staples | 0.82% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
CEL-SCI Corp
CVM
$81.4M
| – | – |
0
| – | – |
|
102
Quest Diagnostics
DGX
$20.1B
| – | – |
-75,000
| Closed | -$8.59M |
|
103
Dyadic International
DYAI
$35.4M
| – | – |
-209,064
| Closed | -$1.58M |
|
104
Elevance Health
ELV
$72.4B
| – | – |
-16,031
| Closed | -$4.31M |
|
105
Esperion Therapeutics
ESPR
$490M
| – | – |
-61,600
| Closed | -$2.29M |
|
106
GoodRx Holdings
GDRX
$1.49B
| – | – |
-1,000
| Closed | -$56K |
|
107
GSK
GSK
$79.3B
| – | – |
-206,638
| Closed | -$7.78M |
|
|
108
Johnson & Johnson
JNJ
$429B
| – | – |
-114,400
| Closed | -$17M |
|
109
Seres Therapeutics
MCRB
$162M
| – | – |
0
| – | – |
|
110
Medtronic
MDT
$118B
| – | – |
-39,000
| Closed | -$4.05M |
|
111
Medifast
MED
$153M
| – | – |
0
| – | – |
|
|
MESO
112
Mesoblast
MESO
$1.65B
| – | – |
0
| – | – |
|
113
PMV Pharmaceuticals
PMVP
$82.1M
| – | – |
-1,000
| Closed | -$36K |
|
114
Quanterix
QTRX
$202M
| – | – |
-124,609
| Closed | -$4.2M |
|